A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1995-03

AUTHORS

Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah, John R. Crison

ABSTRACT

A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS) More... »

PAGES

413-420

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1016212804288

DOI

http://dx.doi.org/10.1023/a:1016212804288

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037126380

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7617530


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1115", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Pharmacology and Pharmaceutical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biological Availability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cimetidine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gastric Emptying", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "In Vitro Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Jejunum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mathematics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Models, Theoretical", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Permeability", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pharmaceutical Preparations", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Piroxicam", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Solubility", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Michigan\u2013Ann Arbor", 
          "id": "https://www.grid.ac/institutes/grid.214458.e", 
          "name": [
            "College of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michigan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amidon", 
        "givenName": "Gordon L.", 
        "id": "sg:person.014127067437.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014127067437.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Uppsala University", 
          "id": "https://www.grid.ac/institutes/grid.8993.b", 
          "name": [
            "School of Pharmacy, Uppsala University, Box 580, S-751 23, Uppsala, Sweden"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lennern\u00e4s", 
        "givenName": "Hans", 
        "id": "sg:person.01372131203.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372131203.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Parenteral Drug Association", 
          "id": "https://www.grid.ac/institutes/grid.479064.8", 
          "name": [
            "PDA, HFD-602, 20857, Rockville, Maryland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shah", 
        "givenName": "Vinod P.", 
        "id": "sg:person.01223074603.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223074603.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "TSRL (United States)", 
          "id": "https://www.grid.ac/institutes/grid.281449.2", 
          "name": [
            "TSRL, Inc., 540 Avis Drive, Suite A, 48108, Ann Arbor, Michigan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Crison", 
        "givenName": "John R.", 
        "id": "sg:person.015752121734.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015752121734.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1018999130076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002102293", 
          "https://doi.org/10.1023/a:1018999130076"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600750202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003026689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600691204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010541473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1994.tb04309.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013748502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600730922", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016268446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(89)90069-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024346420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(89)90069-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024346420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10611869509015945", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027004040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1993.tb05691.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028323223"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/gut.27.8.886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034298308"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015892621261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035241234", 
          "https://doi.org/10.1023/a:1015892621261"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01061761", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036555799", 
          "https://doi.org/10.1007/bf01061761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015909716312", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038769588", 
          "https://doi.org/10.1023/a:1015909716312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/03639048309046315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039109681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015888813741", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040826363", 
          "https://doi.org/10.1023/a:1015888813741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015927004752", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042556047", 
          "https://doi.org/10.1023/a:1015927004752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jps.2600781111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042647529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00562664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044388678", 
          "https://doi.org/10.1007/bf00562664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00562664", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044388678", 
          "https://doi.org/10.1007/bf00562664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(80)90048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045925554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0378-5173(80)90048-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045925554"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015829128646", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047482208", 
          "https://doi.org/10.1023/a:1015829128646"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1018947113238", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051994422", 
          "https://doi.org/10.1023/a:1018947113238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076536863", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0016-5085(90)91150-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078478659"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1995-03", 
    "datePublishedReg": "1995-03-01", 
    "description": "A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS)", 
    "genre": "research_article", 
    "id": "sg:pub.10.1023/a:1016212804288", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2511825", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2508276", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1094644", 
        "issn": [
          "0724-8741", 
          "1573-904X"
        ], 
        "name": "Pharmaceutical Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "name": "A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability", 
    "pagination": "413-420", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b0db9cc6ccd51802b1e31cfa7c11aabc5ba1c73ba893c97a211d72b1b27abceb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7617530"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8406521"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1016212804288"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037126380"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1016212804288", 
      "https://app.dimensions.ai/details/publication/pub.1037126380"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:41", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000506.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1023/A:1016212804288"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1016212804288'


 

This table displays all metadata directly associated to this object as RDF triples.

221 TRIPLES      21 PREDICATES      62 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1016212804288 schema:about N1335f2498cd34b96be64a00e75863b38
2 N25f439bdcf99407a8f2a4c441f7f93dc
3 N33078912c00547cebe733e6e09827ae5
4 N864bae7f62874728bf5c8fd39ab25a92
5 N9409fd15edca47938241d889cced0f62
6 N9e11bdf56f5943c9a2d4903ad87ff4eb
7 Na38b0a276d414c78be8a8f1a3fc984b2
8 Nacde2033635642f3ac1480bbe6f6609d
9 Nc16f9bef507640e688b24044e17ddf38
10 Nf446ed07324742a68a14246d738c427d
11 Nf4697cdb75844f87842c1f09b597aa82
12 anzsrc-for:11
13 anzsrc-for:1115
14 schema:author N9998e178ea3a487cb96f905eede6f8e3
15 schema:citation sg:pub.10.1007/bf00562664
16 sg:pub.10.1007/bf01061761
17 sg:pub.10.1023/a:1015829128646
18 sg:pub.10.1023/a:1015888813741
19 sg:pub.10.1023/a:1015892621261
20 sg:pub.10.1023/a:1015909716312
21 sg:pub.10.1023/a:1015927004752
22 sg:pub.10.1023/a:1018947113238
23 sg:pub.10.1023/a:1018999130076
24 https://app.dimensions.ai/details/publication/pub.1076536863
25 https://doi.org/10.1002/jps.2600691204
26 https://doi.org/10.1002/jps.2600730922
27 https://doi.org/10.1002/jps.2600750202
28 https://doi.org/10.1002/jps.2600781111
29 https://doi.org/10.1016/0016-5085(90)91150-5
30 https://doi.org/10.1016/0378-5173(80)90048-4
31 https://doi.org/10.1016/0378-5173(89)90069-0
32 https://doi.org/10.1111/j.1365-2125.1993.tb05691.x
33 https://doi.org/10.1111/j.1365-2125.1994.tb04309.x
34 https://doi.org/10.1136/gut.27.8.886
35 https://doi.org/10.3109/03639048309046315
36 https://doi.org/10.3109/10611869509015945
37 schema:datePublished 1995-03
38 schema:datePublishedReg 1995-03-01
39 schema:description A biopharmaceutics drug classification scheme for correlating in vitro drug product dissolution and in vivo bioavailability is proposed based on recognizing that drug dissolution and gastrointestinal permeability are the fundamental parameters controlling rate and extent of drug absorption. This analysis uses a transport model and human permeability results for estimating in vivo drug absorption to illustrate the primary importance of solubility and permeability on drug absorption. The fundamental parameters which define oral drug absorption in humans resulting from this analysis are discussed and used as a basis for this classification scheme. These Biopharmaceutic Drug Classes are defined as: Case 1. High solubility-high permeability drugs, Case 2. Low solubility-high permeability drugs, Case 3. High solubility-low permeability drugs, and Case 4. Low solubility-low permeability drugs. Based on this classification scheme, suggestions are made for setting standards for in vitro drug dissolution testing methodology which will correlate with the in vivo process. This methodology must be based on the physiological and physical chemical properties controlling drug absorption. This analysis points out conditions under which no in vitro-in vivo correlation may be expected e.g. rapidly dissolving low permeability drugs. Furthermore, it is suggested for example that for very rapidly dissolving high solubility drugs, e.g. 85% dissolution in less than 15 minutes, a simple one point dissolution test, is all that may be needed to insure bioavailability. For slowly dissolving drugs a dissolution profile is required with multiple time points in systems which would include low pH, physiological pH, and surfactants and the in vitro conditions should mimic the in vivo processes.(ABSTRACT TRUNCATED AT 250 WORDS)
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree false
43 schema:isPartOf N0dd8d777ab30479dbd634052dd36b03b
44 N1ce828dad91a4ab1b6813d2d744578ed
45 sg:journal.1094644
46 schema:name A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
47 schema:pagination 413-420
48 schema:productId N51d8502838a8499897bb266a361c546b
49 N782f1416d26c43689427e4eab068a65a
50 Na02d8b4ce66442c0b19c0df76a0d216f
51 Na3972e17302445df81a661476255305a
52 Nf1a5b735ef3d4ef9930848e5df65d4e3
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037126380
54 https://doi.org/10.1023/a:1016212804288
55 schema:sdDatePublished 2019-04-10T16:41
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N94a1eede80974817bc311d3eedf1b13f
58 schema:url http://link.springer.com/10.1023/A:1016212804288
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N0dd8d777ab30479dbd634052dd36b03b schema:issueNumber 3
63 rdf:type schema:PublicationIssue
64 N1335f2498cd34b96be64a00e75863b38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Solubility
66 rdf:type schema:DefinedTerm
67 N1c83ef001b654888a7f190b841998dea rdf:first sg:person.01372131203.73
68 rdf:rest N7e9d14f07a4b4fb1a0d3e149fae1b02b
69 N1ce828dad91a4ab1b6813d2d744578ed schema:volumeNumber 12
70 rdf:type schema:PublicationVolume
71 N25f439bdcf99407a8f2a4c441f7f93dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Piroxicam
73 rdf:type schema:DefinedTerm
74 N33078912c00547cebe733e6e09827ae5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Mathematics
76 rdf:type schema:DefinedTerm
77 N3e97beb320c14623946c6a89d97ff354 rdf:first sg:person.015752121734.07
78 rdf:rest rdf:nil
79 N51d8502838a8499897bb266a361c546b schema:name pubmed_id
80 schema:value 7617530
81 rdf:type schema:PropertyValue
82 N782f1416d26c43689427e4eab068a65a schema:name nlm_unique_id
83 schema:value 8406521
84 rdf:type schema:PropertyValue
85 N7e9d14f07a4b4fb1a0d3e149fae1b02b rdf:first sg:person.01223074603.31
86 rdf:rest N3e97beb320c14623946c6a89d97ff354
87 N864bae7f62874728bf5c8fd39ab25a92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Gastric Emptying
89 rdf:type schema:DefinedTerm
90 N9409fd15edca47938241d889cced0f62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Permeability
92 rdf:type schema:DefinedTerm
93 N94a1eede80974817bc311d3eedf1b13f schema:name Springer Nature - SN SciGraph project
94 rdf:type schema:Organization
95 N9998e178ea3a487cb96f905eede6f8e3 rdf:first sg:person.014127067437.90
96 rdf:rest N1c83ef001b654888a7f190b841998dea
97 N9e11bdf56f5943c9a2d4903ad87ff4eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name In Vitro Techniques
99 rdf:type schema:DefinedTerm
100 Na02d8b4ce66442c0b19c0df76a0d216f schema:name readcube_id
101 schema:value b0db9cc6ccd51802b1e31cfa7c11aabc5ba1c73ba893c97a211d72b1b27abceb
102 rdf:type schema:PropertyValue
103 Na38b0a276d414c78be8a8f1a3fc984b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Models, Theoretical
105 rdf:type schema:DefinedTerm
106 Na3972e17302445df81a661476255305a schema:name doi
107 schema:value 10.1023/a:1016212804288
108 rdf:type schema:PropertyValue
109 Nacde2033635642f3ac1480bbe6f6609d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Biological Availability
111 rdf:type schema:DefinedTerm
112 Nc16f9bef507640e688b24044e17ddf38 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Jejunum
114 rdf:type schema:DefinedTerm
115 Nf1a5b735ef3d4ef9930848e5df65d4e3 schema:name dimensions_id
116 schema:value pub.1037126380
117 rdf:type schema:PropertyValue
118 Nf446ed07324742a68a14246d738c427d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Cimetidine
120 rdf:type schema:DefinedTerm
121 Nf4697cdb75844f87842c1f09b597aa82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Pharmaceutical Preparations
123 rdf:type schema:DefinedTerm
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1115 schema:inDefinedTermSet anzsrc-for:
128 schema:name Pharmacology and Pharmaceutical Sciences
129 rdf:type schema:DefinedTerm
130 sg:grant.2508276 http://pending.schema.org/fundedItem sg:pub.10.1023/a:1016212804288
131 rdf:type schema:MonetaryGrant
132 sg:grant.2511825 http://pending.schema.org/fundedItem sg:pub.10.1023/a:1016212804288
133 rdf:type schema:MonetaryGrant
134 sg:journal.1094644 schema:issn 0724-8741
135 1573-904X
136 schema:name Pharmaceutical Research
137 rdf:type schema:Periodical
138 sg:person.01223074603.31 schema:affiliation https://www.grid.ac/institutes/grid.479064.8
139 schema:familyName Shah
140 schema:givenName Vinod P.
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01223074603.31
142 rdf:type schema:Person
143 sg:person.01372131203.73 schema:affiliation https://www.grid.ac/institutes/grid.8993.b
144 schema:familyName Lennernäs
145 schema:givenName Hans
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372131203.73
147 rdf:type schema:Person
148 sg:person.014127067437.90 schema:affiliation https://www.grid.ac/institutes/grid.214458.e
149 schema:familyName Amidon
150 schema:givenName Gordon L.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014127067437.90
152 rdf:type schema:Person
153 sg:person.015752121734.07 schema:affiliation https://www.grid.ac/institutes/grid.281449.2
154 schema:familyName Crison
155 schema:givenName John R.
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015752121734.07
157 rdf:type schema:Person
158 sg:pub.10.1007/bf00562664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044388678
159 https://doi.org/10.1007/bf00562664
160 rdf:type schema:CreativeWork
161 sg:pub.10.1007/bf01061761 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036555799
162 https://doi.org/10.1007/bf01061761
163 rdf:type schema:CreativeWork
164 sg:pub.10.1023/a:1015829128646 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047482208
165 https://doi.org/10.1023/a:1015829128646
166 rdf:type schema:CreativeWork
167 sg:pub.10.1023/a:1015888813741 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040826363
168 https://doi.org/10.1023/a:1015888813741
169 rdf:type schema:CreativeWork
170 sg:pub.10.1023/a:1015892621261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035241234
171 https://doi.org/10.1023/a:1015892621261
172 rdf:type schema:CreativeWork
173 sg:pub.10.1023/a:1015909716312 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038769588
174 https://doi.org/10.1023/a:1015909716312
175 rdf:type schema:CreativeWork
176 sg:pub.10.1023/a:1015927004752 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042556047
177 https://doi.org/10.1023/a:1015927004752
178 rdf:type schema:CreativeWork
179 sg:pub.10.1023/a:1018947113238 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051994422
180 https://doi.org/10.1023/a:1018947113238
181 rdf:type schema:CreativeWork
182 sg:pub.10.1023/a:1018999130076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002102293
183 https://doi.org/10.1023/a:1018999130076
184 rdf:type schema:CreativeWork
185 https://app.dimensions.ai/details/publication/pub.1076536863 schema:CreativeWork
186 https://doi.org/10.1002/jps.2600691204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010541473
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1002/jps.2600730922 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016268446
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1002/jps.2600750202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003026689
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1002/jps.2600781111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042647529
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/0016-5085(90)91150-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078478659
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/0378-5173(80)90048-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045925554
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/0378-5173(89)90069-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024346420
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1111/j.1365-2125.1993.tb05691.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028323223
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1111/j.1365-2125.1994.tb04309.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013748502
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1136/gut.27.8.886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034298308
205 rdf:type schema:CreativeWork
206 https://doi.org/10.3109/03639048309046315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039109681
207 rdf:type schema:CreativeWork
208 https://doi.org/10.3109/10611869509015945 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027004040
209 rdf:type schema:CreativeWork
210 https://www.grid.ac/institutes/grid.214458.e schema:alternateName University of Michigan–Ann Arbor
211 schema:name College of Pharmacy, The University of Michigan, 48109-1065, Ann Arbor, Michigan
212 rdf:type schema:Organization
213 https://www.grid.ac/institutes/grid.281449.2 schema:alternateName TSRL (United States)
214 schema:name TSRL, Inc., 540 Avis Drive, Suite A, 48108, Ann Arbor, Michigan
215 rdf:type schema:Organization
216 https://www.grid.ac/institutes/grid.479064.8 schema:alternateName Parenteral Drug Association
217 schema:name PDA, HFD-602, 20857, Rockville, Maryland
218 rdf:type schema:Organization
219 https://www.grid.ac/institutes/grid.8993.b schema:alternateName Uppsala University
220 schema:name School of Pharmacy, Uppsala University, Box 580, S-751 23, Uppsala, Sweden
221 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...